https://www.youtube.com/watch?v=T4U6qvNt81E&feature=youtu.be
The MMTP has recorded this film in support of SENS Research and their quest to find solutions to ALT cancer.
To support OncoSENS project with a donation click the link:
Continue reading “Elena Milova speaking in support of OncoSENS crowdfunding campaign” »
https://www.youtube.com/watch?v=5chIH_ozLkI
Inconvenient truths about aging, senescent cells and more.
Filmed August 16th 2016.
Continue reading “Aubrey de Grey and Panel — Prolonging Lifespan” »
Google’s artificial intelligence research lab DeepMind is exploring whether its technology could be used to identify early signs of eye diseases that ophthalmologists might not spot.
DeepMind, which was acquired by Google in 2014, has struck an agreement with Moorfields Eye Hospital in London that gives it access to about a million anonymous retinal scans, which it will feed into its artificial intelligence software.
Continue reading “Could an algorithm help to save people’s eyesight? Google thinks so” »
It’s an add-on for CRISPR.
Researchers have created a new genome editing technique called Target-AID, which induces point mutations instead of cutting DNA
Gene editing technology has fantastic potential, but there are remaining issues and questions over safety and specificity. The major contender is currently CRISPR-Cas9, but this induces a double stranded break in DNA which is a slightly riskier approach — particularly if it cuts in other locations too that you don’t want it to. Research teams across the world are both optimising and customising the CRISPR system; creating more accurate versions or versions that regulate gene expression as opposed to editing it. One such team has now built an add-on to CRISPR, Target-AID.
Continue reading “Safer Gene Editing Without Cleaving DNA” »
Dr Haroldo Silva from SENS talks about ALT cancer in this short film.
As normal cells divide, the ends of their chromosomes (telomeres) progressively shorten until eventually the cells reach senescence or undergo apoptosis. Cancers, which disproportionally kill more individuals in the 65 years or above age group, often overcome this built-in replication limit by expressing the enzyme telomerase.
Time people rethought outdated ideas about biology and accepted that development and aging are not one way processess and they are amenable to intervention.
Scientists have announced they can now reverse the menopause in what is thought to be a major scientific breakthrough.
Trials claim to have ‘rejuvenated’ women’s ovaries using a blood treatment normally used to help wounds heal faster and have reversed menstrual cessation in multiple women, including 40-year-old woman who underwent the menopause five years ago.
Continue reading “Menopause reversed as scientists successfully ‘rejuvenate women’s ovaries’” »
https://www.youtube.com/watch?v=tKsTWM373xs
Even insurance companies are taking longevity seriously now!
Scientists at Emory University School of Medicine have found that the dietary supplement alpha lipoic acid (ALA) can stimulate telomerase, the enzyme that lengthens telomeres, with positive effects in a mouse model of atherosclerosis.
In human cells, shortened telomeres, the protective caps at the ends of chromosomes, are a sign of aging and also contribute to aging.
Continue reading “Anti-aging effects (in mice) of a dietary supplement called alpha lipoic acid” »
https://www.youtube.com/watch?v=N6eDDIyS_EA
Longevity sticker shock is holding back progress in rejuvenation biotechnology.
Filmed at BIL 2016 in Los Angeles.
